Health Data Analytics Startup Komodo Health’s $220M Series E propels it to $3.3B valuation
Komodo Health announced a $220 million Series E funding round led by Tiger Global Management and joined by Casdin Capital. Existing investors ICONIQ Growth, Andreesen Horowitz, and SVB Capital also participated in the round. The funding has propelled Komodo into the unicorn club with a valuation of $3.3 billion.
Komodo’s primary business is to offer providers, pharma, and other life sciences stakeholders with a variety of services based on its Healthcare Map, an AI and data analytics tool Komodo says is tracking more than 325 million patients’ de-identified healthcare encounters. Its database of de-identified, real-world patient insights is used to provide a longitudinal view of the patient journey at scale to help improve clinical outcomes, address unmet patient needs, close gaps in care, improve engagement, and ultimately help bring novel therapies to market.
The funding will be used to accelerate Komodo Health’s investment in its enterprise technology platform, application suite, and core data assets.
“We had a vision seven years ago that integrating robust data with software solutions was the way forward for healthcare at a time when no one was doing this,” said Komodo Health Co-founder and President Web Sun. “Komodo’s Healthcare Map is now the deepest, most representative, and most powerful engine of healthcare intelligence, and as we build for the future, we are humbled to add Tiger Global and Casdin Capital to the list of premier investors backing us in our relentless effort to further extend our seven-year lead.”
Prior to this $220 million funding round, Komodo closed a $50 million Series C round in January of 2020. It also raised a $44 million Series D round last year, but that funding wasn’t announced until January 2021, when the funding was announced along with Komodo’s acquisition of Mavens, a provider of cloud-based tools geared toward biotech, rare disease, and specialty pharma customers for an undisclosed sum.
Read the original story here.
See the original press release here.
See additional coverage in: